Finance

Lists
Why is HEPA down 50.61%?
Dive Deeper
HEPA:OTCMKTS
Hepion Pharmaceuticals Inc
$0.061
-50.61%
(-0.062) 1D
Oct 13, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HEPA...
Open
$0.12
High
$0.13
Low
$0.06
Mkt. cap
7.74M
Avg. vol.
35.78K
Volume
72.12K
52-wk high
$0.13
52-wk low
$0.03
EPS
-$0.24
Beta
1.75
Shares outstanding
98.22M
No. of employees
2
Open
$0.12
High
$0.13
Low
$0.06
Mkt. cap
7.74M
Avg. vol.
35.78K
Volume
72.12K
52-wk high
$0.13
52-wk low
$0.03
EPS
-$0.24
Beta
1.75
Shares outstanding
98.22M
No. of employees
2
News stories
From web sources and news partners
About Hepion Pharmaceuticals Inc
CEO-
Employees2
Founded2013
Headquarters-
SectorPharmaceutical industry
Websitehepionpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
70.00K
50.92K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
527.90K
609.68K
728.51K
1.16M
Operating expense
527.90K
609.68K
798.51K
1.21M
Total operating expenses
527.90K
609.68K
798.51K
1.21M
Operating income
-527.90K
-609.68K
-798.51K
-1.21M
Other non operating income
-
-
-10.15K
-42.99K
EBT including unusual items
-472.51K
-656.88K
-810.79K
-1.25M
EBT excluding unusual items
-519.79K
-622.26K
-810.79K
-1.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-472.51K
-656.88K
-810.79K
-1.25M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8.12K
-
-
6.24K
Interest expense
-
-12.58K
-2.13K
-
Net interest expenses
8.12K
-12.58K
-2.13K
6.24K
Depreciation and amortization charges
-
-
-
-
EBITDA
-520.21K
-601.99K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps